Bioharvest Sciences, Inc. (TSE:BHSC) has released an update.
Bioharvest Sciences Inc. has expanded its biotech capabilities with a new 80,000 square foot facility in Yavne, Israel, which includes 12 GMP clean rooms and space for a future 50 Ton manufacturing site, set to operate by the second half of 2025. The company, known for its Botanical Synthesis technology, has secured the new campus for approximately 78 months at a cost of USD 5.5 million, with an additional USD 3.6 million equipment purchase. This strategic move aims to support the growth of their CDMO Business Unit and meet the increasing demand for their products.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
